Clinical Trial Update: Observation Study of T-Gel (1%) in Treatment of Adolescent Boys With Hypogonadism [Phase 2]

View source ↗

Summary

This Clinical Trial Update reports the completion of a Phase 2 observational study evaluating T-Gel 1% in adolescent boys with hypogonadism, including primary/s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Constitutional Delay of Growth and Puberty
• Hypogonadism

Drugs mentioned

• T-Gel 1% (testosterone gel 1%)

Snippet

Sponsor: Solvay Pharmaceuticals | Conditions: Primary or Secondary Hypogonadism, Constitutional Delay in Growth and Puberty (CDGP) | Phase 2 | Status: COMPLETED